BACKGROUND: We compared outcomes of arch debranching (AD) and elephant trunk (ET) techniques when used with thoracic endovascular aortic repair. METHODS: A review was performed of consecutive patients with proximal thoracic aortic pathologies repaired with a hybrid approach. RESULTS: Between 2005 and 2009, 58 patients underwent first-stage ET (n = 21) or AD (n = 37). Cardiopulmonary bypass was utilized in 100% of ET procedures and 68% of AD procedures (p < 0.01). Circulatory arrest was used in 86% of ET and 27% of AD cases (p < 0.01). The second stage was completed in 76% of ET and 76% of AD patients. Rates of spinal cord ischemia (ET 0 of 21, AD 0 of 37, p = 1.0), stroke (ET 2 of 21, AD 4 of 37, p = 1.0), and 30-day mortality (ET 4 of 21, AD 6 of 37, p = 1.0) were similar. Each group had one major aortic complication between the two stages. Type Ia endovascular leak at 1 and 12 months occurred in 13% ET patients and 4% AD patients at 1 month (p = 0.54) and in 0% ET patients and 4% AD patients at 12 months (p = 1.0). Kaplan-Meier estimates of survival at 1 and 12 months were 90.5% ± 6.4% and 73.1% ± 10% in the ET group, and 86.5% ± 5.6 and 71.6% ± 8.5 in the AD group, respectively (p = 0.68). The risk of a secondary procedure at 1 and 12 months was 76.2% ± 9.3% and 58.7% ± 12% in the ET group, and 71.0% ± 7.8% and 52.8% ± 10% in the AD group, respectively (p = 0.86). CONCLUSIONS: Arch debranching achieves equivalent results to standard elephant trunk repair but with a decreased need for cardiopulmonary bypass and circulatory arrest. Copyright Â
BACKGROUND: We compared outcomes of arch debranching (AD) and elephant trunk (ET) techniques when used with thoracic endovascular aortic repair. METHODS: A review was performed of consecutive patients with proximal thoracic aortic pathologies repaired with a hybrid approach. RESULTS: Between 2005 and 2009, 58 patients underwent first-stage ET (n = 21) or AD (n = 37). Cardiopulmonary bypass was utilized in 100% of ET procedures and 68% of AD procedures (p < 0.01). Circulatory arrest was used in 86% of ET and 27% of AD cases (p < 0.01). The second stage was completed in 76% of ET and 76% of ADpatients. Rates of spinal cord ischemia (ET 0 of 21, AD 0 of 37, p = 1.0), stroke (ET 2 of 21, AD 4 of 37, p = 1.0), and 30-day mortality (ET 4 of 21, AD 6 of 37, p = 1.0) were similar. Each group had one major aortic complication between the two stages. Type Ia endovascular leak at 1 and 12 months occurred in 13% ETpatients and 4% ADpatients at 1 month (p = 0.54) and in 0% ETpatients and 4% ADpatients at 12 months (p = 1.0). Kaplan-Meier estimates of survival at 1 and 12 months were 90.5% ± 6.4% and 73.1% ± 10% in the ET group, and 86.5% ± 5.6 and 71.6% ± 8.5 in the AD group, respectively (p = 0.68). The risk of a secondary procedure at 1 and 12 months was 76.2% ± 9.3% and 58.7% ± 12% in the ET group, and 71.0% ± 7.8% and 52.8% ± 10% in the AD group, respectively (p = 0.86). CONCLUSIONS: Arch debranching achieves equivalent results to standard elephant trunk repair but with a decreased need for cardiopulmonary bypass and circulatory arrest. Copyright Â
Authors: M P Ehrlich; M A Ergin; J N McCullough; S L Lansman; J D Galla; C A Bodian; A Z Apaydin; R B Griepp Journal: Ann Thorac Surg Date: 2000-06 Impact factor: 4.330
Authors: Ernst Weigang; Jack Parker; Martin Czerny; Ali A Peivandi; Bernhard Dorweiler; Friedhelm Beyersdorf; Michael P Siegenthaler Journal: Ann Thorac Surg Date: 2009-02 Impact factor: 4.330
Authors: Jon S Matsumura; W Anthony Lee; R Scott Mitchell; Mark A Farber; Mohammad Hassan Murad; Alan B Lumsden; Roy K Greenberg; Hazim J Safi; Ronald M Fairman Journal: J Vasc Surg Date: 2009-11 Impact factor: 4.268
Authors: H J Safi; C C Miller; A L Estrera; T T Huynh; F S Rubenstein; M H Subramaniam; L M Buja Journal: Circulation Date: 2001-12-11 Impact factor: 29.690
Authors: C Hagl; M A Ergin; J D Galla; S L Lansman; J N McCullough; D Spielvogel; P Sfeir; C A Bodian; R B Griepp Journal: J Thorac Cardiovasc Surg Date: 2001-06 Impact factor: 5.209
Authors: Steve Xydas; Benjamin Wei; Hiroo Takayama; Mark Russo; Matthew Bacchetta; Craig R Smith; Allan Stewart Journal: J Thorac Cardiovasc Surg Date: 2010-01-18 Impact factor: 5.209
Authors: G Chad Hughes; Mani A Daneshmand; Keki R Balsara; Hardean A Achneck; Bantayehu Sileshi; Sean M Lee; Richard L McCann Journal: Ann Thorac Surg Date: 2009-12 Impact factor: 4.330
Authors: Lars G Svensson; Kyung-Hwan Kim; Eugene H Blackstone; Joan M Alster; Patrick M McCarthy; Roy K Greenberg; Joseph F Sabik; Richard S D'Agostino; Bruce W Lytle; Delos M Cosgrove Journal: Ann Thorac Surg Date: 2004-07 Impact factor: 4.330
Authors: Mohamad Bashir; Matthew Fok; Richard G McWilliams; Michael Desmond; Mark Field; Robert K Fisher; Aung Oo; Manoj Kuduvalli Journal: Aorta (Stamford) Date: 2013-09-01
Authors: Igor Voskresensky; Salvatore T Scali; Robert J Feezor; Javairiah Fatima; Kristina A Giles; Rosamaria Tricarico; Scott A Berceli; Adam W Beck Journal: J Vasc Surg Date: 2017-07 Impact factor: 4.268
Authors: Ehsan Benrashid; Hanghang Wang; Jeffrey E Keenan; Nicholas D Andersen; James M Meza; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2015-10-27 Impact factor: 4.268
Authors: Nicholas D Andersen; Judson B Williams; Jennifer M Hanna; Asad A Shah; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2012-11-24 Impact factor: 4.268
Authors: Konstantinos G Moulakakis; Spyridon N Mylonas; Fotis Markatis; Thomas Kotsis; John Kakisis; Christos D Liapis Journal: Ann Cardiothorac Surg Date: 2013-05